As a result, miR-425 was closely related to immune checkpoints such as CD160, CD200R1, and CD80, and immune pathways including CD56bright natural killer cell and monocyte in CRC progression (Figure 6A). This evidence concerns the gene CD80 and colorectal carcinoma.